Despite repeated warnings over the years and extensive labeling requirements and standards, tragic errors related to the inadvertent administration of vincristine intrathecally (into the subarachnoid space), rather than intravenously, continue to occur. And, while such events occur infrequently, such "wrong route" errors are very preventable.